Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated:  9/15/2015
Retina Consultants of Michigan
mi
from
Southfield, MI
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Retina Consultants of Michigan
mi
from
Southfield, MI
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated:  9/15/2015
Retina Group of Washington
mi
from
Chevy Chase, MD
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Retina Group of Washington
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated:  9/15/2015
Retina Group of Washington
mi
from
Fairfax, VA
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Retina Group of Washington
mi
from
Fairfax, VA
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated:  9/15/2015
Retina Health Center
mi
from
Ft. Myers, FL
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Retina Health Center
mi
from
Ft. Myers, FL
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated:  9/15/2015
Retina Research Center
mi
from
Austin, TX
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Retina Research Center
mi
from
Austin, TX
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated:  9/15/2015
Retina Research Institute of Texas, LLC
mi
from
Abilene, TX
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Retina Research Institute of Texas, LLC
mi
from
Abilene, TX
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated:  9/15/2015
Retina Specialists
mi
from
Towson, MD
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Retina Specialists
mi
from
Towson, MD
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated:  9/15/2015
Retina Specialty Institute
mi
from
Pensacola, FL
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Retina Specialty Institute
mi
from
Pensacola, FL
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated:  9/15/2015
Retina-Vitreous Associates Medical Group
mi
from
Beverly Hills, CA
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Retina-Vitreous Associates Medical Group
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated:  9/15/2015
Retinal Consultants Medical Group, Inc.
mi
from
Sacramento, CA
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Retinal Consultants Medical Group, Inc.
mi
from
Sacramento, CA
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated:  9/15/2015
Retinal Diagnostic Center
mi
from
Campbell, CA
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Retinal Diagnostic Center
mi
from
Campbell, CA
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated:  9/15/2015
Rocky Mountain Retina Consultants
mi
from
Salt Lake City, UT
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Rocky Mountain Retina Consultants
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated:  9/15/2015
Sagar Kenyon American Eye Institute
mi
from
New Albany, CA
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Sagar Kenyon American Eye Institute
mi
from
New Albany, CA
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated:  9/15/2015
Specialty Eye Care Medical Center
mi
from
Glendale, CA
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Specialty Eye Care Medical Center
mi
from
Glendale, CA
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated:  9/15/2015
Spokane Eye Clinical Research
mi
from
Spokane, WA
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Spokane Eye Clinical Research
mi
from
Spokane, WA
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated:  9/15/2015
Texas Retina Associates
mi
from
Dallas, TX
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Texas Retina Associates
mi
from
Dallas, TX
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated:  9/15/2015
TLC Eye Care and Laser Center
mi
from
Jackson, MI
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
TLC Eye Care and Laser Center
mi
from
Jackson, MI
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated:  9/15/2015
Valley Retina Institute
mi
from
Harlingen, TX
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Valley Retina Institute
mi
from
Harlingen, TX
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated:  9/15/2015
Henry Ford Health System
mi
from
Detroit, MI
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Henry Ford Health System
mi
from
Detroit, MI
Click here to add this to my saved trials
Study to Assess the Safety and Effects of Cells Injected Intravitreal in Dry Macular Degeneration
An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Injected Intravitreal in Dry Macular Degeneration
Status: Enrolling
Updated:  9/15/2015
Bioheart
mi
from
Sunrise, FL
Study to Assess the Safety and Effects of Cells Injected Intravitreal in Dry Macular Degeneration
An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Injected Intravitreal in Dry Macular Degeneration
Status: Enrolling
Updated: 9/15/2015
Bioheart
mi
from
Sunrise, FL
Click here to add this to my saved trials
SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma
Randomized, Controlled, Multicenter Comparative Trial to Evaluate the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Glaucomatous Eyes Following Failed Medical and Conventional Surgical Treatments
Status: Enrolling
Updated:  9/17/2015
North Bay Eye Associates
mi
from
Petaluma, CA
SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma
Randomized, Controlled, Multicenter Comparative Trial to Evaluate the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Glaucomatous Eyes Following Failed Medical and Conventional Surgical Treatments
Status: Enrolling
Updated: 9/17/2015
North Bay Eye Associates
mi
from
Petaluma, CA
Click here to add this to my saved trials
SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma
Randomized, Controlled, Multicenter Comparative Trial to Evaluate the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Glaucomatous Eyes Following Failed Medical and Conventional Surgical Treatments
Status: Enrolling
Updated:  9/17/2015
Glaucoma Consultants of Colorado
mi
from
Littleton, CO
SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma
Randomized, Controlled, Multicenter Comparative Trial to Evaluate the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Glaucomatous Eyes Following Failed Medical and Conventional Surgical Treatments
Status: Enrolling
Updated: 9/17/2015
Glaucoma Consultants of Colorado
mi
from
Littleton, CO
Click here to add this to my saved trials
SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma
Randomized, Controlled, Multicenter Comparative Trial to Evaluate the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Glaucomatous Eyes Following Failed Medical and Conventional Surgical Treatments
Status: Enrolling
Updated:  9/17/2015
International Eye Care
mi
from
Tampa, FL
SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma
Randomized, Controlled, Multicenter Comparative Trial to Evaluate the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Glaucomatous Eyes Following Failed Medical and Conventional Surgical Treatments
Status: Enrolling
Updated: 9/17/2015
International Eye Care
mi
from
Tampa, FL
Click here to add this to my saved trials
SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma
Randomized, Controlled, Multicenter Comparative Trial to Evaluate the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Glaucomatous Eyes Following Failed Medical and Conventional Surgical Treatments
Status: Enrolling
Updated:  9/17/2015
Price Vision Group
mi
from
Indianapolis, IN
SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma
Randomized, Controlled, Multicenter Comparative Trial to Evaluate the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Glaucomatous Eyes Following Failed Medical and Conventional Surgical Treatments
Status: Enrolling
Updated: 9/17/2015
Price Vision Group
mi
from
Indianapolis, IN
Click here to add this to my saved trials
SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma
Randomized, Controlled, Multicenter Comparative Trial to Evaluate the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Glaucomatous Eyes Following Failed Medical and Conventional Surgical Treatments
Status: Enrolling
Updated:  9/17/2015
Eagle Mountain Vision
mi
from
Tulsa, OK
SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma
Randomized, Controlled, Multicenter Comparative Trial to Evaluate the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Glaucomatous Eyes Following Failed Medical and Conventional Surgical Treatments
Status: Enrolling
Updated: 9/17/2015
Eagle Mountain Vision
mi
from
Tulsa, OK
Click here to add this to my saved trials
SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma
Randomized, Controlled, Multicenter Comparative Trial to Evaluate the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Glaucomatous Eyes Following Failed Medical and Conventional Surgical Treatments
Status: Enrolling
Updated:  9/17/2015
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma
Randomized, Controlled, Multicenter Comparative Trial to Evaluate the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Glaucomatous Eyes Following Failed Medical and Conventional Surgical Treatments
Status: Enrolling
Updated: 9/17/2015
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma
Randomized, Controlled, Multicenter Comparative Trial to Evaluate the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Glaucomatous Eyes Following Failed Medical and Conventional Surgical Treatments
Status: Enrolling
Updated:  9/17/2015
University of Medicine and Dentistry of New Jersey
mi
from
Newark, NJ
SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma
Randomized, Controlled, Multicenter Comparative Trial to Evaluate the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Glaucomatous Eyes Following Failed Medical and Conventional Surgical Treatments
Status: Enrolling
Updated: 9/17/2015
University of Medicine and Dentistry of New Jersey
mi
from
Newark, NJ
Click here to add this to my saved trials
SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma
Randomized, Controlled, Multicenter Comparative Trial to Evaluate the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Glaucomatous Eyes Following Failed Medical and Conventional Surgical Treatments
Status: Enrolling
Updated:  9/17/2015
Glaucoma Associates of New York
mi
from
New York, NY
SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma
Randomized, Controlled, Multicenter Comparative Trial to Evaluate the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Glaucomatous Eyes Following Failed Medical and Conventional Surgical Treatments
Status: Enrolling
Updated: 9/17/2015
Glaucoma Associates of New York
mi
from
New York, NY
Click here to add this to my saved trials
SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma
Randomized, Controlled, Multicenter Comparative Trial to Evaluate the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Glaucomatous Eyes Following Failed Medical and Conventional Surgical Treatments
Status: Enrolling
Updated:  9/17/2015
University of Tennessee / Hamilton Eye Institute
mi
from
Memphis, TN
SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma
Randomized, Controlled, Multicenter Comparative Trial to Evaluate the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Glaucomatous Eyes Following Failed Medical and Conventional Surgical Treatments
Status: Enrolling
Updated: 9/17/2015
University of Tennessee / Hamilton Eye Institute
mi
from
Memphis, TN
Click here to add this to my saved trials
SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma
Randomized, Controlled, Multicenter Comparative Trial to Evaluate the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Glaucomatous Eyes Following Failed Medical and Conventional Surgical Treatments
Status: Enrolling
Updated:  9/17/2015
Credit Valley EyeCare
mi
from
Mississauga,
SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma
Randomized, Controlled, Multicenter Comparative Trial to Evaluate the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Glaucomatous Eyes Following Failed Medical and Conventional Surgical Treatments
Status: Enrolling
Updated: 9/17/2015
Credit Valley EyeCare
mi
from
Mississauga,
Click here to add this to my saved trials
Non-invasive Ocular Surface Measurements Before and After Interventions
Non-invasive Ocular Surface Measurements Before and After Interventions
Status: Enrolling
Updated:  9/17/2015
The Flaum Eye Institute-University of Rochester
mi
from
Rochester, NY
Non-invasive Ocular Surface Measurements Before and After Interventions
Non-invasive Ocular Surface Measurements Before and After Interventions
Status: Enrolling
Updated: 9/17/2015
The Flaum Eye Institute-University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD
Evaluation of Genetic Variants in Patients With Type 1 Neovascularization (Sub-retinal Pigment Epithelium Neovascularization) Who Lack Typical Findings of Age Related Macular Degeneration (AMD) But Present With Findings More Consistent With Long-standing Central Serous Chorioretinopathy (CSC).
Status: Enrolling
Updated:  9/17/2015
Vitreous Retina Macula Consultants of New York, P.C.
mi
from
New York City, NY
Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD
Evaluation of Genetic Variants in Patients With Type 1 Neovascularization (Sub-retinal Pigment Epithelium Neovascularization) Who Lack Typical Findings of Age Related Macular Degeneration (AMD) But Present With Findings More Consistent With Long-standing Central Serous Chorioretinopathy (CSC).
Status: Enrolling
Updated: 9/17/2015
Vitreous Retina Macula Consultants of New York, P.C.
mi
from
New York City, NY
Click here to add this to my saved trials
A Study of Simbrinza™ Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  9/17/2015
Clinical Research Facility
mi
from
Wheaton, IL
A Study of Simbrinza™ Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 9/17/2015
Clinical Research Facility
mi
from
Wheaton, IL
Click here to add this to my saved trials
Lens Fitting Evaluation of CooperVision MyDay™ Compared With 1-DAY ACUVUE® TruEye® and DAILIES TOTAL1®
Lens Fitting Evaluation of CooperVision MyDay™ Compared With 1-DAY ACUVUE® TruEye® and DAILIES TOTAL1®
Status: Enrolling
Updated:  9/18/2015
Clinical Research Center, University of California, Berkeley
mi
from
Berkeley, CA
Lens Fitting Evaluation of CooperVision MyDay™ Compared With 1-DAY ACUVUE® TruEye® and DAILIES TOTAL1®
Lens Fitting Evaluation of CooperVision MyDay™ Compared With 1-DAY ACUVUE® TruEye® and DAILIES TOTAL1®
Status: Enrolling
Updated: 9/18/2015
Clinical Research Center, University of California, Berkeley
mi
from
Berkeley, CA
Click here to add this to my saved trials
FST-100 in the Treatment of Acute Adenoviral Conjunctivitis
A Proof-of-Concept, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of FST-100 Ophthalmic Suspension in the Treatment of Acute Adenoviral Conjunctivitis
Status: Enrolling
Updated:  9/22/2015
ORA Inc
mi
from
Andover, MA
FST-100 in the Treatment of Acute Adenoviral Conjunctivitis
A Proof-of-Concept, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of FST-100 Ophthalmic Suspension in the Treatment of Acute Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/22/2015
ORA Inc
mi
from
Andover, MA
Click here to add this to my saved trials
FST-100 in the Treatment of Acute Adenoviral Conjunctivitis
A Proof-of-Concept, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of FST-100 Ophthalmic Suspension in the Treatment of Acute Adenoviral Conjunctivitis
Status: Enrolling
Updated:  9/22/2015
Ora, Inc.
mi
from
Noida,
FST-100 in the Treatment of Acute Adenoviral Conjunctivitis
A Proof-of-Concept, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of FST-100 Ophthalmic Suspension in the Treatment of Acute Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/22/2015
Ora, Inc.
mi
from
Noida,
Click here to add this to my saved trials
Investigating Age-Related Macular Degeneration
Age-Related Macular Degeneration: A Genetic Epidemiology Study in the Amish
Status: Enrolling
Updated:  9/26/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Investigating Age-Related Macular Degeneration
Age-Related Macular Degeneration: A Genetic Epidemiology Study in the Amish
Status: Enrolling
Updated: 9/26/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab or Ranibizumab
Pilot Study for the Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab Avastin or Ranibizumab Lucentis
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab or Ranibizumab
Pilot Study for the Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab Avastin or Ranibizumab Lucentis
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
ANTI-TAC THERAPY FOR UVEITIS
Trial of Treatment of Non-Infectious Intermediate and Posterior Uveitis With Humanized Anti-Tac Antibody Therapy
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
ANTI-TAC THERAPY FOR UVEITIS
Trial of Treatment of Non-Infectious Intermediate and Posterior Uveitis With Humanized Anti-Tac Antibody Therapy
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Screening for Studies on Inherited Eye Diseases
Screening Study for the Evaluation and Diagnosis of Potential Research Subjects With Inherited Ophthalmic Diseases
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Screening for Studies on Inherited Eye Diseases
Screening Study for the Evaluation and Diagnosis of Potential Research Subjects With Inherited Ophthalmic Diseases
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Screening for Studies on Retinovascular Diseases
Screening Study for the Evaluation and Diagnosis of Potential Research Subjects With Retinovascular Diseases
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Screening for Studies on Retinovascular Diseases
Screening Study for the Evaluation and Diagnosis of Potential Research Subjects With Retinovascular Diseases
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Screening for NEI Clinical Studies
Screening Study for the Evaluation and Diagnosis of Potential Research Subjects With Ocular Inflammatory or Immunologic Diseases
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Screening for NEI Clinical Studies
Screening Study for the Evaluation and Diagnosis of Potential Research Subjects With Ocular Inflammatory or Immunologic Diseases
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Screening for Studies on Nystagmus and Strabismus
Screening Study for the Evaluation and Diagnosis of Potential Research Subjects With Nystagmus or Strabismus
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Screening for Studies on Nystagmus and Strabismus
Screening Study for the Evaluation and Diagnosis of Potential Research Subjects With Nystagmus or Strabismus
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Blood Factors and Diabetic Retinopathy
Study of Association of Serum Factors With Diabetic Retinopathy
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Blood Factors and Diabetic Retinopathy
Study of Association of Serum Factors With Diabetic Retinopathy
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Evaluation and Treatment of Patients With Retinal Disease
Evaluation and Treatment Protocol for Patients With Retinal Disease
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Evaluation and Treatment of Patients With Retinal Disease
Evaluation and Treatment Protocol for Patients With Retinal Disease
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Evaluation and Treatment of Patients With Inflammatory Eye Diseases
Evaluation and Treatment Protocol for Patients With Intraocular Inflammatory Disease (Uveitis)
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Evaluation and Treatment of Patients With Inflammatory Eye Diseases
Evaluation and Treatment Protocol for Patients With Intraocular Inflammatory Disease (Uveitis)
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Evaluation and Treatment of Patients With Corneal and External Diseases
Evaluation and Treatment of Corneal and External Diseases and Anterior Segment Disorders
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Evaluation and Treatment of Patients With Corneal and External Diseases
Evaluation and Treatment of Corneal and External Diseases and Anterior Segment Disorders
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Evaluation and Treatment of Patients With Inherited Eye Diseases
Evaluation and Treatment Protocol for Potential Research Subjects With Inherited Ophthalmic Diseases
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Evaluation and Treatment of Patients With Inherited Eye Diseases
Evaluation and Treatment Protocol for Potential Research Subjects With Inherited Ophthalmic Diseases
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Identification and Treatment of Feeder Vessels in Macular Degeneration
Feasibility Study of the Identification and Treatment of Feeder-Vessels of Choroidal Neovascularization in Age-Related Macular Degeneration
Status: Enrolling
Updated:  9/26/2015
National Eye Institute (NEI)
mi
from
Bethesda, MD
Identification and Treatment of Feeder Vessels in Macular Degeneration
Feasibility Study of the Identification and Treatment of Feeder-Vessels of Choroidal Neovascularization in Age-Related Macular Degeneration
Status: Enrolling
Updated: 9/26/2015
National Eye Institute (NEI)
mi
from
Bethesda, MD
Click here to add this to my saved trials
Prevalence and Risk of Cataracts in Granulocyte Donors
Prevalence and Risks for Posterior Subcapsular Cataracts in Volunteer Granulocytapheresis Donors
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Prevalence and Risk of Cataracts in Granulocyte Donors
Prevalence and Risks for Posterior Subcapsular Cataracts in Volunteer Granulocytapheresis Donors
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials